莱茵生物：335.40万股限售股将于11月21日上市流通

Core Points - Rhine Biotech announced the third unlock period for its 2022 restricted stock incentive plan, allowing 67 individuals to unlock a total of 3.354 million shares, which represents 0.45% of the company's total share capital of 741.609425 million shares [1] Summary by Category Company Actions - The company has confirmed that 67 individuals meet the conditions for unlocking their restricted stock [1] - The total number of shares that can be unlocked is 3.354 million [1] - The unlock date for these shares is set for November 21, 2025 [1]